Center for American Progress Action

Medicare Patient With Diabetes Will Save Thousands With Insulin Copay Cap
Personal Story • Last updated on Aug 9, 2023

Medicare Patient With Diabetes Will Save Thousands With Insulin Copay Cap

A Missouri woman with Type 1 diabetes can afford to purchase a home with the incoming savings from the Inflation Reduction Act’s insulin copay cap.

August 9, 2023

Robin Craycroft, licensed therapist and older American with Type 1 diabetes
Springfield, Missouri

Nearly 4 million Medicare recipients live with diabetes, and many of them struggle to afford their insulin. Since the $35 insulin Medicare copay cap was implemented in January 2023, Robin Craycroft has experienced the life-changing impact of the Inflation Reduction Act.

Photo shows Robin Craycroft wearing a colorful, floral shirt standing on a deck with green trees in the background

Robin Craycroft is pictured in August 2022. (Photo credit: Dennis Craycroft)

President Biden's Inflation Reduction Act changed our lives. It allowed us to pay the remaining credit card balance for the previous year of insulin, increase our savings, and take a trip to see our precious grandsons. We experienced their love, joy, and hugs in person—which was unforgettable! Robin Craycroft

Among other important health care provisions, the $35 insulin copay cap finally holds Big Pharma accountable for profiting off the backs of Americans such as Robin. Since its enactment, the three largest insulin manufacturers have moved to reduce some insulin product prices for people not on Medicare.

Read more about the benefits of the Inflation Reduction Act

Americans celebrate how the Inflation Reduction Act has benefited their lives in the year since its passage.

December 12, 2022

As the price of insulin surged for more than a decade, patients with diabetes had no choice but to pay thousands of dollars in copays or risk comas by rationing insulin. For Missouri resident Robin Craycroft, the price of her insulin under Medicare brought her to shock and tears at the pharmacy.

When Robin was 61 years old, she was diagnosed with latent autoimmune diabetes—a condition that causes Type 1 diabetes. After she enrolled in Medicare last year at age 65, her insulin costs went from $35 per month to more than $1,000 upon hitting the Medicare coverage gap. The first time Robin saw the price, she teared up in the pharmacy line. The only thing she could do was hand over her credit card to purchase her insulin and pay it off over time. She wants to retire, but the high cost of her prescription medications requires her to continue working part time. Once she heard about the Biden administration enacting the Inflation Reduction Act to cap insulin copays at $35 per month, she cried tears of joy. In anticipation of thousands of dollars in savings, Robin and her husband plan to purchase a home and enjoy retirement unburdened by the stress of rising insulin costs.

With my insulin costs capped at $35 a month, my husband and I can finally save to purchase a house. We are thrilled. Instead of crying in the pharmacy, I am crying tears of joy. Robin Craycroft

Robin and millions of other Medicare recipients with diabetes will finally have relief from high insulin prices with the $35 copay cap from the Inflation Reduction Act. The provision will not just save money; it will save lives.

Read more on how laws passed under Biden have helped Americans

This collection features stories from Americans across the country whose lives and communities have benefited from the legislative and executive actions passed under the Biden administration.

The positions of American Progress, and our policy experts, are independent, and the findings and conclusions presented are those of American Progress alone. A full list of supporters is available here. American Progress would like to acknowledge the many generous supporters who make our work possible.


Digital Advocacy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.